Purpose:Ensure the development of appropriate regulatory strategyies and their execution for for early and/or late stage HIV or other assigned assets consistent with Medicines Development Strategy/Integrated Asset Plan IAP. This goal has to be achieved both as a component of an overall global regulatory approach and ensure compliance with both internal GSK process / policy and with regional regulatory requirements to deliver the best possible labeling, commensurate with the available data.Responsibilities and AccountabilitiesAccountable to GRL if one assigned and/or Global Regulatory thera...
